Answers are grounded in this paper and cite their sources.
This guideline presents direction regarding treatment and management of SLE and provides a foundation for well-informed, shared clinician-patient decision-making. These recommendations should not be used to limit or deny access to therapies, as treatment decisions may vary due to the unique clinical situation and personal preferences of each person with SLE.
No takes yet. Share an insight, caveat, or question.
Sammaritano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: